Gumming Up the Works: DNA Polymers As HCV Entry Inhibitors

Overview

Journal Gastroenterology

Specialty Gastroenterology

Date 2009 Jul 1

PMID 19563837

Citations 2

Authors

Natalie A Counihan

Brett D Lindenbach

Affiliations

Soon will be listed here.

Citing Articles

Oligonucleotides designed to inhibit TLR9 block Herpes simplex virus type 1 infection at multiple steps.

Sauter M, Gauger J, Brandt C Antiviral Res. 2014; 109:83-96.

PMID: 24995383 PMC: 4135040. DOI: 10.1016/j.antiviral.2014.06.015.

Targeting cell entry of enveloped viruses as an antiviral strategy.

Teissier E, Penin F, Pecheur E Molecules. 2011; 16(1):221-50.

PMID: 21193846 PMC: 6259279. DOI: 10.3390/molecules16010221.

References

Kocisko D, Vaillant A, Lee K, Arnold K, Bertholet N, Race R . Potent antiscrapie activities of degenerate phosphorothioate oligonucleotides. Antimicrob Agents Chemother. 2006; 50(3):1034-44. PMC: 1426446. DOI: 10.1128/AAC.50.3.1034-1044.2006. View

Zeisel M, Koutsoudakis G, Schnober E, Haberstroh A, Blum H, Cosset F . Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81. Hepatology. 2007; 46(6):1722-31. DOI: 10.1002/hep.21994. View

Cormier E, Tsamis F, Kajumo F, Durso R, Gardner J, Dragic T . CD81 is an entry coreceptor for hepatitis C virus. Proc Natl Acad Sci U S A. 2004; 101(19):7270-4. PMC: 409908. DOI: 10.1073/pnas.0402253101. View

Germi R, Crance J, Garin D, Guimet J, Lortat-Jacob H, Ruigrok R . Cellular glycosaminoglycans and low density lipoprotein receptor are involved in hepatitis C virus adsorption. J Med Virol. 2002; 68(2):206-15. DOI: 10.1002/jmv.10196. View

Agnello V, Abel G, Elfahal M, Knight G, Zhang Q . Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci U S A. 1999; 96(22):12766-71. PMC: 23090. DOI: 10.1073/pnas.96.22.12766. View

Ploss A, Evans M, Gaysinskaya V, Panis M, You H, de Jong Y . Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature. 2009; 457(7231):882-6. PMC: 2762424. DOI: 10.1038/nature07684. View

Catanese M, Graziani R, von Hahn T, Moreau M, Huby T, Paonessa G . High-avidity monoclonal antibodies against the human scavenger class B type I receptor efficiently block hepatitis C virus infection in the presence of high-density lipoprotein. J Virol. 2007; 81(15):8063-71. PMC: 1951280. DOI: 10.1128/JVI.00193-07. View

Evans M, von Hahn T, Tscherne D, Syder A, Panis M, Wolk B . Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature. 2007; 446(7137):801-5. DOI: 10.1038/nature05654. View

Vaillant A, Juteau J, Lu H, Liu S, Lackman-Smith C, Ptak R . Phosphorothioate oligonucleotides inhibit human immunodeficiency virus type 1 fusion by blocking gp41 core formation. Antimicrob Agents Chemother. 2006; 50(4):1393-401. PMC: 1426958. DOI: 10.1128/AAC.50.4.1393-1401.2006. View

10.

Guzman E, Cheshenko N, Shende V, Keller M, Goyette N, Juteau J . Amphipathic DNA polymers are candidate vaginal microbicides and block herpes simplex virus binding, entry and viral gene expression. Antivir Ther. 2008; 12(8):1147-56. View

11.

Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R . Binding of hepatitis C virus to CD81. Science. 1998; 282(5390):938-41. DOI: 10.1126/science.282.5390.938. View

12.

Lozach P, Amara A, Bartosch B, Virelizier J, Arenzana-Seisdedos F, Cosset F . C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles. J Biol Chem. 2004; 279(31):32035-45. DOI: 10.1074/jbc.M402296200. View

13.

Scarselli E, Ansuini H, Cerino R, Roccasecca R, Acali S, Filocamo G . The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J. 2002; 21(19):5017-25. PMC: 129051. DOI: 10.1093/emboj/cdf529. View

14.

Matsumura T, Hu Z, Kato T, Dreux M, Zhang Y, Imamura M . Amphipathic DNA polymers inhibit hepatitis C virus infection by blocking viral entry. Gastroenterology. 2009; 137(2):673-81. PMC: 2803092. DOI: 10.1053/j.gastro.2009.04.048. View

15.

Pohlmann S, Zhang J, Baribaud F, Chen Z, Leslie G, Lin G . Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J Virol. 2003; 77(7):4070-80. PMC: 150620. DOI: 10.1128/jvi.77.7.4070-4080.2003. View

16.

Lozach P, Lortat-Jacob H, de Lacroix de Lavalette A, Staropoli I, Foung S, Amara A . DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. J Biol Chem. 2003; 278(22):20358-66. DOI: 10.1074/jbc.M301284200. View

17.

Zhang J, Randall G, Higginbottom A, Monk P, Rice C, McKeating J . CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J Virol. 2004; 78(3):1448-55. PMC: 321402. DOI: 10.1128/jvi.78.3.1448-1455.2004. View

18.

Gardner J, Durso R, Arrigale R, Donovan G, Maddon P, Dragic T . L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus. Proc Natl Acad Sci U S A. 2003; 100(8):4498-503. PMC: 153584. DOI: 10.1073/pnas.0831128100. View

19.

Bartosch B, Vitelli A, Granier C, Goujon C, Dubuisson J, Pascale S . Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J Biol Chem. 2003; 278(43):41624-30. DOI: 10.1074/jbc.M305289200. View

20.

Cormier E, Durso R, Tsamis F, Boussemart L, Manix C, Olson W . L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus. Proc Natl Acad Sci U S A. 2004; 101(39):14067-72. PMC: 521122. DOI: 10.1073/pnas.0405695101. View